Zdrowie i gospodarka · 30/08/2017
FDA Clears CENESTIN Tablets for Approval
The FDA has determined that CENESTIN Tablets in various doses were not withdrawn from sale due to safety or effectiveness concerns, paving the way for potential approval of abbreviated new drug applications.